MedComm Introduction

2020-02-28

Open the phone and scan



Introduction of MedComm

 

Chief Editor:

Prof. James Henderson Naismith 

Prof. Yuquan Wei

 

Profile

Profile MedComm is a peer-reviewed, online open access (OA) journal. The journal publishes a wide variety of works that provide novel insights into all aspects of medicine on the basis of novelty, timeliness and significance to human health. Original works can enjoy "fast track" mode for publication, which can be as soon as one week, and publication fee is waived for works submitted from 2020 to 2022. MedComm sincerely welcome all quality works from scientific researchers, doctors, and graduate students in the field of biomedicine.


Editor-in-Chief

Arnold JM Driessen

Groningen Biomolecular Sciences and Biotechnology Institut, University of Groningen  Professor at the University of Groningen, former director of Groningen Biomolecular Sciences and Biotechnology Institute, and one of the founders of the Center for Synthetic Biology and the Center for Sustainable Antibacterial (CESAM) both in Groningen. A member of the Royal Netherlands Academy of Arts and Sciences. Chairman of the Dutch Society of Biochemistry and Molecular Biology. Member of consortium assembly of Building a Synthetic Cell (BaSyc). He has received awards including the Kluyver Award of KNVM and the FEBS Anniversary Prize of the Society for Biological Chemistry. He also serves as managing editor of Extremophiles, and chaired several conferences of the European Science Foundation, European Molecular Biology Organization, and Gordon Research Conference. He has authored more than 460 research papers, authored and edited two books, and (co-)invented 11 patents. Prof. Driessen is an outstanding scientist whose papers are highly cited (over 32,000 times) with an academic h-index of 97.





Yuquan Wei

State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, Sichuan University, China Ph.D., Professor and Director of National/State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, academician of Chinese Academy of Sciences. He was educated at West China University of Medical Sciences for a bachelor's degree in Medicine and a Master's Degree in Medicine, and educated at Kyoto University in Japan for a Doctoral Degree. His major research interests include targeted therapy, signal transduction, gene and cell therapy, and cancer vaccines. He has published more than 300 papers in international journals including Nature, Nat Med, Nat Commun, PNAS, Blood, Cancer Res, Clinic Cancer Res, J Immunol, and J Biol Chem, etc. He is now President of China Medicinal Biotech Association. He has served as the cheif editor of Signal Transduction and Targeted Therapy, an associate editor of Human Gene Therapy and Editorial Board Member of several International Journals.